Takeda Pharmaceuticals North America

Part of Takeda

Organisation

Trials

  • NCT04119336

    Collaborator, Phase 2, Terminated, 2 people, 8 Oct 2019

  • NCT01799850

    Collaborator, Phase 4, Completed, 12 people, 27 Feb 2013

  • NCT01588470

    Collaborator, Phase 4, Completed, 130 people, 1 May 2012

  • NCT01161394

    Collaborator, Phase 4, Completed, 24 people, 13 Jul 2010

  • NCT01156597

    Collaborator, Phase 3, Completed, 30 people, 5 Jul 2010

  • NCT01112982

    Collaborator, Phase 4, Completed, 74 people, 29 Apr 2010

  • NCT00982202

    Collaborator, Phase 2, Completed, 25 people, 23 Sept 2009

  • NCT00835120

    Collaborator, Phase 4, Completed, 34 people, 3 Feb 2009

  • NCT00782795

    Collaborator, Phase 2, Completed, 64 people, 31 Oct 2008

  • NCT00770367

    Collaborator, Phase 4, Completed, 36 people, 10 Oct 2008

  • NCT00671515

    Collaborator, Phase 2, Completed, 23 people, 5 May 2008

  • NCT00521742

    Collaborator, Phase 3, Completed, 300 people, 28 Aug 2007

  • NCT00443755

    Collaborator, Phase 2, Completed, 28 people, 6 Mar 2007

  • NCT00402012

    Collaborator, Phase 4, Completed, 24 people, 22 Nov 2006

  • NCT00315146

    Collaborator, Phase 4, Completed, 88 people, 17 Apr 2006

  • NCT00242177

    Collaborator, Phase 1, Completed, 30 people, 19 Oct 2005

  • NCT00227110

    Collaborator, Phase 4, Completed, 55 people, 27 Sept 2005

  • NCT00220961

    Collaborator, Phase 3, Completed, 602 people, 22 Sept 2005

  • NCT00091949

    Collaborator, Phase 3, Completed, 3,876 people, 22 Sept 2004